Document:

FORM OF NON-COMPETITION AGREEMENT

 

Exhibit 10.2

  

NON-COMPETITION AGREEMENT

AMONG

ACCENTURE LTD

and

THE PARTNERS PARTY HERETO

Dated as of April 18, 2001

		
	 Table of Contents

	
	 Page   

	 			
				
	
Section 1. Non-Competition Covenants
		3	
	

	
	
Section 2. Remedies Upon Breach
		8	
	

	
	
Section 3. Governing Law
		9	
	

	
	
Section 4. Resolution of Disputes
		9	
	

	
	
Section 5. Amendment; Waiver
		11	
	

	
	
Section 6. Notice
		11	
	

	
	
Section 7. Severability
		12	
	

	
	
Section 8. Change in Control
		12	
	

	
	
Section 9. Entire Agreement
		13	
	

	
	
Section 10. Further Assurances
		13	
	

	
	
Section 11. Execution in Counterparts
		13	
	

	
	       Appendix A – Competitive Enterprises	
	

	
	       Appendix B – Liquidated Damages	
	

	
	       Appendix C – Pledge Agreement	

 

     This Non-Competition Agreement, dated as of April 18, 2001 (as amended, supplemented, waived or otherwise modified from time to time in accordance with its terms, this “Agreement”), among
Accenture Ltd, an exempted company limited by shares organized under the laws of Bermuda (registered number EC30090) (“Accenture Ltd”), and the Partners (hereinafter defined). 

 
 WITNESSETH:

 
     WHEREAS, each Partner is currently obligated to protect the value of his or her Member Firm(s) through certain non-competition and confidentiality covenants (the “Current Agreements”); and

 
     WHEREAS, in connection with the worldwide reorganization of the business and operations of the Accenture Worldwide Organization currently conducted through the Member Firm Inter-Firm organization
structure (“Accenture”) into a unified corporate holding company structure with Accenture Ltd as the top-tier holding company, and Accenture SCA, a Luxembourg société en commandite par actions (“Accenture
SCA”), as the second-tier holding company (the “Transaction”), each of the Accenture partners will exchange their ownership interests in his or her Member Firm(s) for shares of Accenture Ltd or Accenture SCA, as the case may be
(including, in the case of Canadian Accenture partners, shares of a Canadian indirect subsidiary of Accenture Ltd which, for purposes of this Agreement, shall be treated as Accenture Ltd shares); and 

 
     WHEREAS, each Partner acknowledges and agrees that, in connection with and as a result of the Transaction, such Partner will receive shares of Accenture Ltd, which will materially benefit the Partner;
and 

 

     WHEREAS, each Partner acknowledges and agrees that the consideration such Partner will receive in connection with the Transaction is in exchange for the Partner’s interests in his or her Member
Firm(s) that the Partner is transferring directly or indirectly to Accenture Ltd; and 

 

   WHEREAS, each Partner acknowledges and agrees that it is essential to the success of the initial public offering (“IPO”) by Accenture Ltd of its Class A common shares and the enterprise in the
future, and it will be so represented in connection therewith, that the Member Firm interests that are being transferred by the Accenture partners to Accenture Ltd or Accenture SCA in connection with the Transaction be protected by non-competition
agreements similar to the Current Agreements; and 

 
   WHEREAS, each Partner acknowledges and agrees that in connection with the Transaction, and in the course of such Partner’s subsequent employment with Accenture Ltd or its affiliates, the Partner has been and
will be provided with access to sensitive and proprietary information about the clients, prospective clients, knowledge capital and business practices of Accenture Ltd or its affiliates, and has been and will be provided with the opportunity to
develop relationships with clients, prospective clients, employees and other agents of Accenture Ltd or its affiliates, and each Partner further acknowledges that such proprietary information and relationships are extremely valuable assets in which
Accenture Ltd or its affiliates have invested and will continue to invest substantial time, effort and expense and which represent a significant component of the value of the Transaction to the other owners of Accenture Ltd and the owners of
Accenture SCA; and 

 
   WHEREAS, each Partner acknowledges and agrees that the other owners of Accenture Ltd and the owners of Accenture SCA would suffer significant and irreparable harm from such Partner competing with Accenture Ltd or
its affiliates for a period of time after the IPO or after the termination of the Partner’s employment with Accenture Ltd or its affiliates; and 

 
     WHEREAS, each Partner agrees that he or she is willing to enter into this Agreement on the basis of, and in consideration of, all or substantially all of the Accenture partners entering into this
Agreement or similar agreements; and 

 
     WHEREAS, it is a condition precedent to each Partner participating in the Transaction that such Partner agree to be bound by the covenants contained herein; 

 
     NOW, THEREFORE, for good and valuable consideration, each Partner and Accenture Ltd (each, a “Party”; collectively, the “Parties”) hereby covenant and agree to the following
restrictions which the Partner acknowledges and agrees are reasonable and necessary for the other owners of Accenture Ltd and the owners of Accenture SCA to have and enjoy the full benefit of the business interests acquired in connection with the
Transaction and which will not unnecessarily or unreasonably restrict such Partner’s professional opportunities should his or her employment with Accenture Ltd or its affiliates terminate: 

 
     Section 1. Non-Competition Covenants 

 
     (a) Each Partner shall not, for a period ending on the later of five (5) years following the date of the IPO, or eighteen (18) months following the termination of such Partner’s employment
with Accenture Ltd or any of its affiliates (the “Restricted Period”): 

 
     (i) associate (including, but not limited to, association as a sole proprietor, owner, employer, partner, principal, investor, joint venturer, shareholder, associate, employee, member,
consultant, contractor or otherwise) with any Competitive Enterprise or any of the affiliates, related entities, successors, or assigns of any Competitive Enterprise and in connection with such association engage in Consulting Services, provided,
however, that with respect to the equity of any Competitive Enterprise which is or becomes publicly traded, such Partner’s ownership as a passive investor of less than 1% of the outstanding publicly traded stock of a Competitive Enterprise
shall not be deemed a violation of Section 1(a)(i) of this Agreement; 

 

     (ii) directly or indirectly (a) solicit, or assist any other individual, person, firm or other entity in soliciting, any Client or Prospective Client for the purpose of performing or providing
any Consulting Services; or (b) perform or provide, or assist any other individual, person, firm or other entity in performing or providing, Consulting Services for any Client or Prospective Client; or (c) interfere with or damage (or attempt to
interfere with or damage) any relationship and/or agreement between Accenture Ltd or any of its affiliates and a Client or Prospective Client; or 

 
     (iii) directly or indirectly, solicit, employ or retain, or assist any other individual, person, firm or other entity in soliciting, employing or retaining, any employee or other agent of
Accenture Ltd or any of its affiliates, including, without limitation, any former employee or other agent of Accenture Ltd or any of its affiliates or any of their predecessors (including, but not limited to, Accenture and any of its affiliates) who
ceased working for Accenture Ltd or any of its affiliates or any of their predecessors within an eighteen month period before or after the date on which such Partner’s employment with Accenture Ltd or any of its affiliates terminated, in
connection with or for the purpose of performing or providing Consulting Services. 

 
     (b) For purposes of this Agreement, the following definitions shall apply: 

 
     (i) The term “Act” shall mean the Securities Exchange Act of 1934, as amended, or any successor thereto. 

 
     (ii) The term “Beneficial Owner” shall mean a beneficial owner as such term is defined in Rule 13d-3 under the Act (or any successor rule thereto). 

 
     (iii) The term “Board” shall mean the Board of Directors of Accenture Ltd. 

 
     (iv) The term “Change in Control” shall mean the occurrence of any of the following events: 

 

     (a) any Person (other than (i) a Person holding securities representing 10% or more of the combined voting power of Accenture Ltd’s outstanding securities as of the date of the IPO (a
“Pre-Existing Shareholder”), (ii) Accenture Ltd, any trustee or other fiduciary holding securities under an employee benefit plan of Accenture Ltd, or (iii) any company owned, directly or indirectly, by the shareholders of Accenture Ltd in
substantially the same proportions as their ownership of shares of Accenture Ltd) becomes the Beneficial Owner, directly or indirectly, of securities of Accenture Ltd, representing (I) 20% or more of the combined voting power of Accenture Ltd’s
then-outstanding securities and (II) more of the combined voting power of Accenture Ltd’s then-outstanding Shares than the Pre-Existing Shareholders in the aggregate; 

 
     (b) during any period of twenty-four consecutive months (not including any period prior to the IPO), individuals who at the beginning of such period constitute the Board, and any new director
(other than a director nominated by any Person (other than Accenture Ltd) who publicly announces an intention to take or to consider taking actions (including, but not limited to, an actual or threatened proxy contest) which if consummated would
constitute a Change in Control under (a), (c) or (d) of this Section 1(b)(iv)) whose election by the Board or nomination for election by Accenture Ltd’s shareholders was approved by a vote of at least two-thirds of the directors then still in
office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority thereof; 

 
     (c) the consummation of any transaction or series of transactions resulting in a merger or consolidation, in which Accenture Ltd is involved, other than a merger or consolidation which would
result in the shareholders of Accenture Ltd immediately prior thereto continuing to own (either by remaining outstanding or by being converted into voting securities of the surviving entity), in the same proportion as immediately prior to the
transaction(s), more than 50% of the combined voting power of the voting securities of Accenture Ltd or such surviving entity outstanding immediately after such merger or consolidation; or 

 

     (d) the complete liquidation of Accenture Ltd or the sale or disposition by Accenture Ltd of all or substantially all of Accenture Ltd’s assets, other than a liquidation of Accenture Ltd
into a wholly-owned subsidiary. 

 
     (v) The term “Client” shall mean any person, firm, corporation or other organization whatsoever for whom Accenture Ltd or any of its affiliates or any of their predecessors (including,
but not limited to, Accenture and its affiliates) provided services within an eighteen month period before or after the date on which the Partner’s employment with Accenture Ltd or any of its affiliates terminated. 

 
     (vi) The term “Competitive Enterprise” shall mean a business enterprise that engages in, or owns or controls a significant interest in any entity that engages in, the performance of
services of the type provided by Accenture Ltd or any of its affiliates or any of their predecessors (including, but not limited to, Accenture and its affiliates) at any time, past, present or future. “Competitive Enterprise”shall include,
but not be limited to, the entities set forth on Appendix A hereto. Accenture Ltd may publish to the Partners from time to time a revised Appendix A. 

     (vii) The term “Consulting Services” shall mean the performance of any services of the type provided by Accenture Ltd or any of its affiliates or any of their predecessors (including,
but not limited to, Accenture and its affiliates) at any time, past, present or future. 

     (viii) The term “employment” shall mean employment by and/or engagement with Accenture Ltd or any of its affiliates. 

     (ix) The term “Partners” (each, a “Partner”) shall mean those persons other than Accenture Ltd who agree to be bound hereby.  

     (x) The term “Person” shall mean a person as such term is used for purposes of Section 13(d) or 14(d) of the Act. 

 
     (xi) The term “Prospective Client” shall mean any person, firm, corporation, or other organization whatsoever with whom Accenture Ltd or any of its affiliates or any of their
predecessors (including, but not limited to, Accenture and its affiliates) have had any negotiations or discussions regarding the possible performance of services within the eighteen months preceding the Partner’s termination of employment with
Accenture Ltd or any of its affiliates. 

 
     (xii) The term “Shares” shall mean the Class A common shares of Accenture Ltd. 

 
     (xiii) The term “solicit” shall mean to have any direct or indirect communication of any kind whatsoever, regardless of by whom initiated, inviting, advising, encouraging or requesting
any person or entity, in any manner, to take or refrain from taking any action. 

 
     (c) Each Partner’s Country Company Managing Director is authorized to waive any or all of the foregoing restrictions, or any portion thereof, provided, however, that the Country Company
Managing Director must first obtain the written consent to such waiver of the Chief Executive Officer of Accenture Ltd, who may grant or withhold such consent in his or her sole and absolute discretion. 

 

     Section 2. Remedies Upon Breach 

 
     (a) Damages 

 
     Each Partner agrees that if such Partner were to breach any provisions of this Agreement, Accenture Ltd would suffer damages that are not readily ascertainable. Accordingly, in addition to and without
limiting any remedies in law or in equity that may be available to Accenture Ltd for the breach of this Agreement, including, but not limited to, injunctive and other equitable relief, each Partner agrees that in the event of a breach of this
Agreement by such Partner, as reasonably determined by the Board of Directors of Accenture Ltd, such Partner shall pay to Accenture Ltd immediately following such determination and a written demand therefor, a cash payment in the amount designated
for such Partner on Appendix B hereto or such lesser amount as may be designated by the Board of Directors of Accenture Ltd in its sole and absolute discretion, as and for liquidated damages (“Liquidated Damages”). Each Partner
acknowledges and agrees that the payment required by this Section is a reasonable forecast of the damages likely to result from such breach and is not a penalty of any kind. 

 
     Each Partner agrees that the Liquidated Damages shall be secured by the shares of Accenture Ltd received by the Partner in the Transaction, pursuant to the Pledge Agreement dated as of the date hereof,
attached as Appendix C hereto (“Pledge Agreement”), which is incorporated herein by reference and made a part of this Agreement. 

 
     Each Partner further agrees that the payment of Liquidated Damages shall not be construed as a release or waiver by Accenture Ltd of the right to prevent the continuation of any such breach of this
Agreement in equity or otherwise and shall not preclude or be construed to preclude Accenture Ltd from making a showing of irreparable injury or any other element that may be necessary to secure injunctive relief. 

 

     (b) Injunctive Relief 

 
     Each Partner acknowledges and agrees that Accenture Ltd’s remedy at law for any breach of the covenants contained herein would be inadequate and that for any breach of such covenants, Accenture
Ltd shall, in addition to other remedies as may be available to it at law or in equity, or as provided for in this Agreement, be entitled to an injunction, restraining order, or other equitable relief, without the necessity of posting a bond,
restraining the Partner from committing or continuing to commit any violation of the covenants. Each Partner agrees that proof shall not be required that monetary damages for breach of the provisions of this Agreement would be difficult to calculate
and that remedies at law would be inadequate. 

 
     Section 3. Governing Law 

 
     This Agreement and the rights and duties of the Parties thereunder shall be governed by and construed and enforced in accordance with the laws of the State of New York, without regard to principles of
conflicts of laws. 

 
     Section 4. Resolution of Disputes

 
     (a) Any and all disputes arising out of, relating to or in connection with this Agreement and/or the Pledge Agreement (together, the “Agreements”), including, but not limited to,
disputes relating to the validity, negotiation, execution, interpretation, performance or non-performance of the Agreements (including the validity, scope and enforceability of this arbitration provision), shall be finally settled by arbitration
conducted by a single arbitrator in New York. The proceedings shall be conducted pursuant to the then-existing Rules of Arbitration of the International Chamber of Commerce, except that the Parties may select an arbitrator who is a national of the
same country as one of the Parties. If the Parties to the dispute fail to agree on the selection of an arbitrator within thirty (30) days of the receipt of request for arbitration, either Party may apply to the International Chamber of Commerce to
make the appointment. The arbitrator shall be a lawyer and shall conduct the proceedings in the English language. 

 
     (b) Notwithstanding the provisions of Paragraph (a) of this Section 4, Accenture Ltd may bring an action or special proceeding in any court of competent jurisdiction for the purpose of
compelling a Partner to arbitrate, seeking temporary or preliminary relief pending resolution of a dispute between the Parties and/or enforcing an arbitration award, and, for the purposes of this Paragraph (b), each Partner (i) expressly consents to
the application of Paragraph (c) of this Section 4 to any such action or proceeding and (ii) irrevocably appoints the General Counsel of Accenture Ltd, c/o Accenture Ltd, 1661 Page Mill Road, Palo Alto, CA 94304 (or, if different, the then-current
principal business address of the duly appointed General Counsel of Accenture Ltd) as such Partner’s agent for service of process in connection with any such action or proceeding and agrees that service of process upon such agent, who shall
promptly advise such Partner of any such service of process, shall be deemed in every respect effective service of process upon the Partner in any such action or proceeding. 

 
     (c) (i) The Parties hereby irrevocably submit to the non-exclusive jurisdiction of the courts of the State of New York and the courts of the United States of America located in the State of New
York for the purpose of any judicial proceeding brought in accordance with the provisions of Paragraph (b) of this Section 4, or any judicial proceeding ancillary to an arbitration or contemplated arbitration arising out of or relating to or
concerning the Agreements. Such ancillary judicial proceedings include any suit, action or proceeding to compel arbitration, to obtain temporary or preliminary judicial relief in aid of arbitration, or to confirm an arbitration award. The Parties
acknowledge that the for a designated by this Paragraph (c) have a reasonable relation to the Agreements, and to the Parties’ relationship with one another. 

 

 
     (ii) The Parties hereby waive, to the fullest extent permitted by applicable law, any objection which they now or hereafter may have to personal jurisdiction or to the laying of venue of any such
ancillary suit, action or proceeding brought in any court referred to in Paragraph (c)(i) of this Section 4, and the Parties agree not to plead or claim the same. 

 
     Section 5. Amendment; Waiver 

 
     This Agreement may not be modified, other than by a written agreement executed by the Partner and Accenture Ltd, nor may any provision hereof be waived other than by a writing executed by Accenture
Ltd. 

 
     The waiver by Accenture Ltd of any particular default by a Partner shall not affect or impair the rights of Accenture Ltd with respect to any subsequent default of the same or of a different kind by
such Partner or a different Partner; nor shall any delay or omission by Accenture Ltd to exercise any right arising from any default by a Partner affect or impair any rights that Accenture Ltd may have with respect to the same or any future default
by such Partner or a different Partner. 

 
     Section 6. Notice 

 
     (a) Any communication, demand or notice to be given hereunder will be duly given (and shall be deemed to be received) when delivered in writing by hand or first class mail or by telecopy to a
party at its address as indicated below: 

     If to a Partner,

           c/o Accenture Ltd

           1661 Page Mill Road

           Palo Alto, CA 94304

           Telecopy: (650) 213-2956

           Attention: General Counsel

           (or, if different, the then-current principal business address of the duly

           appointed General Counsel of Accenture Ltd)

      If to Accenture Ltd,

           Accenture Ltd

           1661 Page Mill Road

           Palo Alto, CA 94304

           Telecopy: (650) 213-2956

           Attention: General Counsel

           (or, if different, the then-current principal business address of the duly

           appointed General Counsel of Accenture Ltd)  

     (b) Accenture Ltd shall be responsible for notifying each Partner of the receipt of a communication, demand or notice under this Agreement relevant to such Partner, in writing, at the address of
such Partner then in the records of Accenture Ltd (and each Partner shall notify Accenture Ltd of any change in such address for communications, demands and notices) or by electronic mail to the principal electronic address of such person maintained
by Accenture Ltd. 

 
     (c) Unless otherwise provided to the contrary herein, any notice which is required to be given in writing pursuant to the terms of this Agreement may be given by telecopy. 

 
     Section 7. Severability 

 
     If any provision of this Agreement shall be held or deemed to be invalid, illegal, or unenforceable in any jurisdiction, for any reason, the invalidity of that provision shall not have the effect of
rendering the provision in question unenforceable in any other jurisdiction or in any other case or of rendering any other provisions herein unenforceable, but the invalid provision shall be substituted with a valid provision which most closely
approximates the intent and the economic effect of the invalid provision and which would be enforceable to the maximum extent permitted in such jurisdiction or in such case. 

 
     Section 8. Change in Control 

 
     Notwithstanding any provision in this Agreement to the contrary, this Agreement shall terminate in the event of a Change in Control after the IPO. 

 

     Section 9. Entire Agreement 

 
     This Agreement and the Pledge Agreement contain the entire agreement between the Parties with respect to the subject matter therein and supersede all prior oral and written agreements between the
Parties pertaining to such matters. 

 
     Section 10. Further Assurances 

 
     Each Partner agrees to execute all such further instruments and documents and to take all such further action as may be reasonably necessary to effect the terms and purposes of this Agreement.

 
     Section 11. Execution in Counterparts 

 
     This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute one agreement. 

 

     IN WITNESS WHEREOF, the parties hereto have duly executed or caused to be duly executed this Non-Competition Agreement as of the date first above written. 

 

ACCENTURE LTD

By _________________________________

      Name:

      Title:

 

 

[Signature blocks of Partners set forth separately.]

 

 

 

APPENDIX C TO NON-COMPETITION AGREEMENT

 

PLEDGE AGREEMENT 

     PLEDGE AGREEMENT, dated as of April 18, 2001 (this “Agreement”), among Accenture Ltd, an exempted company limited by shares organized under the laws of Bermuda (registered number
EC30090) (“Accenture Ltd”), and each other entity and individual, other than the Pledgee, agreeing to be bound hereby (each, a “Pledgor” and, collectively, the “Pledgors”). Terms used herein and not
otherwise defined shall have the meanings ascribed to them in the Non-Competition Agreement referred to below. 

 

WITNESSETH 

     WHEREAS, in connection with each Pledgor’s participation in the Transaction, each Partner and Accenture Ltd have entered into the Non-Competition Agreement attached hereto (the
“Non-Competition Agreement”), into which this Agreement is incorporated by reference and of which this Agreement is a part, in respect of, inter alia, each Partner’s obligations not to engage in competitive activities and not
to solicit Accenture Ltd’s clients or employees for the Restricted Period (the “Obligations”). In addition, each Partner has agreed under the Non-Competition Agreement to certain provisions regarding choice of law, arbitration,
injunctive relief and submission to jurisdiction with respect to the enforcement of the Obligations. 

 
     WHEREAS, pursuant to the Non-Competition Agreement, each Partner has agreed to pay a certain amount of liquidated damages (with respect to any Partner, such Partner’s “Liquidated
Damages”) to Accenture Ltd in respect of any breach by such Partner of the Obligations set forth in the Non-Competition Agreement. As security for the timely payment of the Liquidated Damages, each Pledgor has agreed to pledge to Accenture
Ltd all of such Pledgor’s Covered Shares, as such term is defined in the Voting Agreement, dated as of April 18, 2001 (as amended, supplemented, waived or otherwise modified from time to time in accordance with its terms, the
“Voting Agreement”), among Accenture Ltd and the Covered Persons (defined therein) (the “Covered Shares”). 

 
     NOW, THEREFORE, in consideration of the promises contained herein and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as
follows: 

 
     1. Pledge.  (a) As collateral security for the full and timely payment of Liquidated Damages, each Pledgor hereby pledges to Accenture Ltd and creates for the benefit of
Accenture Ltd a perfected first priority security interest in the Covered Shares in which such Pledgor now has or at any time in the future may acquire any right, title or interest (and all certificates or other instruments or documents evidencing
the Covered Shares, if any) and, except as set forth in Section 2(a), all proceeds thereof (together with any securities or property to be delivered to Accenture Ltd pursuant to Section 2(b)) and, upon substitution or delivery in accordance with
Section l(b), any Substitute Collateral (as defined in Section 1(b)) and all proceeds thereof (collectively, the “Pledged Securities”). Notwithstanding the foregoing, at the request of a Pledgor and upon the prior written consent of
Accenture Ltd (which consent shall be granted in the sole discretion of Accenture Ltd), such Pledgor may grant a first priority security interest in the Pledged Securities to another entity (a “Permitted Prior Pledgee”), in which
case, the pledge by such Pledgor hereunder shall be a second priority security interest in the Pledged Securities.

 

     (b) During the term of this Agreement, a Pledgor may substitute for Pledged Securities readily marketable direct obligations of the United States, any agency thereof, or any triple-A
rated sovereign, or other collateral acceptable to Accenture Ltd in its sole and absolute discretion (such collateral, other than Covered Shares, the “Substitute Collateral”) with a Fair Market Value on the date of substitution
equal to or greater than the Fair Market Value on such date of the Pledged Securities to be released in exchange therefor. Upon such substitution, the Pledged Securities replaced by such Substitute Collateral shall be released from the pledge
hereunder. Each Pledgor agrees to deliver to Accenture Ltd such documents and to take such action deemed necessary or appropriate by Accenture Ltd to give Accenture Ltd a first priority perfected security interest in the Substitute Collateral,
provided that in cases where a security interest in the Pledged Securities has been granted to a Permitted Prior Pledgee, Accenture Ltd shall receive a second priority perfected security interest in the Substitute Collateral.

 
     (c) If a Pledgor is not prohibited from doing so by the terms of the Voting Agreement or any other written agreement with Accenture Ltd, or any law or regulation or Accenture Ltd policy
(collectively, the “Restrictions”) and, if at the time of the transfer, no Payment Event (as defined below) has occurred or is continuing with respect to such Pledgor (or the Partner who controls such Pledgor), this Agreement shall
not prohibit such Pledgor from disposing of Covered Shares and receiving the proceeds thereof (such disposition, a “Permitted Disposition”).

 
     (d) For purposes of this Agreement, the “Fair Market Value” of any Pledged Security means, as of any date (1) in the case of Pledged Securities that are Class A common
shares of Accenture Ltd (the “Class A common shares”) or Accenture Canada Exchangeco Exchangeable Shares (as such term is defined in the Voting Agreement), the average of the daily closing prices for Class A common shares of
Accenture Ltd on the principal securities exchange or market on which the Class A common shares are traded for the 20 consecutive business days before the date in question (the “Average Closing Price”); provided, however, that the
Fair Market Value of Class A common shares or Accenture Canada Exchangeco Exchangeable Shares for purposes of determining the amount of Substitute Collateral necessary to deliver in lieu of the Covered Shares during the first 20 business days
following the date of the IPO shall be deemed to be the initial public offering price in the initial public offering by Accenture Ltd of its Class A common shares; and provided, further, that in connection with any enforcement of the security
interest granted hereunder by Accenture Ltd in respect of the Class A common shares or Accenture Canada Exchangeco Exchangeable Shares under Section 3 hereof, the Average Closing Price shall be determined as the average of the daily closing prices
for Class A common shares on the principal securities exchange or market on which the Class A common shares are traded for the 20 consecutive business days before the date the Enforcement Notice (as hereafter defined) was given, and (2) otherwise,
the fair market value thereof as determined in good faith by the board of directors of Accenture Ltd. Any good faith determination by the board of directors of Accenture Ltd of the Fair Market Value of any Pledged Security will be binding on each
Pledgor.

 

     (e) Each Pledgor shall deliver to Accenture Ltd, promptly upon receipt thereof, all certificates or other instruments or documents, if any, evidencing the Pledged Securities together with
such other documents deemed necessary or appropriate by Accenture Ltd to give Accenture Ltd control (as defined in the Uniform Commercial Code of the State of New York (the “UCC”)) or otherwise to perfect the security interest
granted hereunder (such transfer powers and other appropriate documents, the “Perfection Documents”) in respect of Pledged Securities, and will deliver Perfection Documents for all Pledged Securities to be pledged hereunder from
time to time. Each Pledgor hereby authorizes the issuer of any Covered Shares issued to such Pledgor and any transfer agent in respect of such Covered Shares to deliver any certificate or other instruments or documents, if any, evidencing such
Covered Shares to Accenture Ltd or its delegate.

     2. Administration of Security. The following provisions shall govern the administration of Pledged Securities:  
     (a) (1) So long as no Payment Event (as defined below) has occurred and is continuing with respect to a Pledgor (or the Partner who controls such Pledgor), such Pledgor shall (subject to
the terms of the Voting Agreement) be entitled to vote Pledged Securities and to exercise all of such Pledgor’s rights in respect of the Pledged Securities (subject to the terms of the Voting Agreement), and to receive and retain all cash
dividends and distributions or interest in respect of Pledged Securities and, except as set forth in Section 2(b) below, other distributions thereon and to give consents, waivers and, if applicable, ratifications in respect thereof. As used herein,
a “Payment Event”, as to any Pledgor, shall mean the failure by such Pledgor (or the Partner who controls such Pledgor) to make any payment of Liquidated Damages upon demand by Accenture Ltd therefor as provided in the
Non-Competition Agreement.

          (2) Notwithstanding the other provisions contained herein, so long as no Payment Event has occurred and is continuing with respect to a Pledgor (or the Partner who controls
such Pledgor), such Pledgor shall be entitled to receive the proceeds from Permitted Dispositions of Pledged Securities pursuant to and subject to Section 1(c) hereof. 
     (b) If a Pledgor becomes entitled to receive, or receives, any certificate representing Pledged Securities (or other share or security that may succeed Pledged Securities or any share or
security issued as a dividend or distribution in respect of Pledged Securities) in respect of any stock split, reverse share split, share dividend, spinoff, splitup, merger or other combination, exchange or distribution in connection with any
reclassification, increase or reduction of capital, in each case, with respect to Pledged Securities, Pledgor agrees to deliver to Accenture Ltd such documents and to take such action deemed necessary or appropriate by Accenture Ltd to give
Accenture Ltd a first priority perfected security interest in such certificates, as additional collateral security for Liquidated Damages, provided that in cases where a security interest in the Pledged Securities has been granted to a Permitted
Prior Pledgee, Accenture Ltd shall receive a second priority perfected security interest in such collateral.

 
     (c) Each Pledgor hereby agrees that Accenture Ltd is authorized to hold (other than, in relation to shares in Accenture Ltd (“Accenture Ltd Shares”), if any, owned by
such Pledgor, to the extent prohibited by Bermuda law) Pledged Securities through one or more custodians or, in relation to any Pledged Securities, to engage any agent or agents to enforce its rights under this Agreement in respect of the Pledged
Securities in which case the identity of such custodian or agent shall be made known to the relevant Pledgor if and when required by applicable law. Accenture Ltd and its agents (and its and their assigns) shall have no obligation in respect of
Pledged Securities, except to hold (other than, in relation to Accenture Ltd Shares, to the extent prohibited by Bermuda law) and dispose, or direct the disposition of, or purchase the Pledged Shares in accordance with the terms of this Agreement.
In the event that a Pledgor substitutes cash for Pledged Securities as provided in Section l(b), Accenture Ltd shall determine in its sole discretion the manner in which such cash shall be invested during the term of this Agreement.

 
     (d) Each Pledgor agrees with Accenture Ltd that: (i) such Pledgor will not, and will not purport to, grant or suffer liens or encumbrances against (excluding for such purpose the Voting
Agreement and such liens and encumbrances granted to or in favor of Permitted Prior Pledgees and Accenture Ltd), or except as provided in Section 1(c), sell, transfer or dispose of, any Pledged Securities other than to or in favor of a Permitted
Prior Pledgee or Accenture Ltd; (ii) Accenture Ltd is authorized, at any time and from time to time, to file financing statements and other recording instruments and give notice to third parties regarding Pledged Securities without such
Pledgor’s signature to the extent permitted by applicable law, to transfer all or any part of the Pledged Securities (other than the Accenture Ltd Shares, to the extent prohibited by Bermuda law) to Accenture Ltd’s name or that of its
nominee, and, subject to the provisions of Section 2(a), to exercise all rights as if the absolute owner thereof; and (iii) each Pledgor shall, promptly upon request by Accenture Ltd, provide Accenture Ltd with such Pledgor’s true legal name
and principal residence or chief executive office and jurisdiction of organization, and, thereafter, such Pledgor will not change such Pledgor’s name or address or chief executive office or jurisdiction of organization without 30 days’
prior written notice to Accenture Ltd.

 
     (e) Subject to the earlier disposition and application of Pledged Securities pursuant to this Agreement following a Payment Event in respect of a Pledgor (or the Partner who controls such
Pledgor), Pledged Securities pledged by a Pledgor under this Agreement shall be released from the pledge hereunder, and the lien hereby created in such Pledged Securities shall simultaneously be released, upon the earliest to occur of (i) such
Pledgor’s death or the death of the Partner who controls such Pledgor, (ii) the expiration of the Restricted Period, (iii) payment in cash or other satisfaction by such Pledgor of all Liquidated Damages, (iv) the Permitted Disposition of such
Pledged Securities or (v) a Change in Control. Notwithstanding the foregoing, no Pledged Securities pledged by a Pledgor pursuant to this Agreement shall be released from the pledge hereunder pursuant to this Section 2(e), if a Payment Event has
occurred and is continuing with respect to such Pledgor (or the Partner who controls such Pledgor) or if there are one or more pending disputes between such Pledgor and Accenture Ltd as to the occurrence of a Payment Event or as to the right of
Accenture Ltd to exercise its remedies under this Agreement or the Non-Competition Agreement, including realization against Pledged Securities in accordance with Section 3 hereof, and this Agreement shall not terminate until the resolution of all
such disputes.

 

     (f) Accenture Ltd shall immediately upon request by a Pledgor execute and deliver to such Pledgor such instruments, deeds, transfers, assurances and agreements, in form and substance as
such Pledgor shall reasonably request, including the withdrawal or termination of any financing statements and amendments thereto, or the filing, withdrawal, termination or amendment of any other document required under applicable law to evidence
the termination of the security interest created hereunder with respect to any securities that are released from the pledge hereunder in accordance with the provisions of this Agreement.

 
     3. Remedies in Case of a Payment Event. (a) If a Payment Event has occurred and is continuing with respect to a Pledgor (or the Partner who controls such Pledgor), Accenture Ltd
shall have the rights and remedies of a secured party under Article 9 of the UCC to the extent permitted by applicable law with respect to such Pledgor.

 
     (b) If Accenture Ltd elects to sell the Pledged Securities pledged by a Pledgor as a remedy hereunder, to the extent required and permitted by applicable law, Accenture Ltd will give such Pledgor
notice of the time and place of any public sale or of the time after which any private sale or other disposition of such Pledged Securities is to be made, by sending notice at least three days before the time of sale or disposition, which each
Pledgor hereby agrees is reasonable. Accenture Ltd need not give such notice if not required by the UCC or other applicable law. Each Pledgor acknowledges the possibility that the public sale of some or all Pledged Securities by Accenture Ltd may
not be made without a then existing and effective registration statement under the Securities Act of 1933, as amended. Each Pledgor acknowledges and agrees with Accenture Ltd that Accenture Ltd has no affirmative obligation to prepare or keep
effective any such registration statement and agrees that at any private sale Pledged Securities pledged by a Pledgor may be sold at a price that is less than the price which might have been obtained at a public sale or that is less than the
aggregate outstanding amount of Liquidated Damages of such Pledgor (or the Partner who controls such Pledgor). Any proceeds from the sale of such Pledged Securities in excess of the then outstanding Liquidated Damages of such Pledgor (or the Partner
who controls such Pledgor) will continue to be held as Pledged Securities under this Agreement until returned in accordance with Section 2(e). 

 
     (c) Accenture Ltd may, as a remedy hereunder and to the extent permitted by applicable law, (i) take ownership of or (ii) purchase in accordance with S42A of the Companies Act 1981 of Bermuda, in each
case, such number of Pledged Securities which are Accenture Ltd Shares pledged by a Pledgor as have a value (based upon the Fair Market Value thereof) equal to, or as near as possible equal to, the then unpaid portion of Liquidated Damages of such
Pledgor (or the Partner who controls such Pledgor) (in either case, without payment of any cash consideration to the Pledgor) by giving written notice to the applicable Pledgor (the “Enforcement Notice”). Effective upon the giving
of the Enforcement Notice, and without further action on the part of the parties to this Agreement, Accenture Ltd shall be deemed to have (1) taken ownership (to the extent permitted by applicable law) or purchased, and disposed of the lesser of (A)
all such Pledged Securities or (B) such whole number of such Pledged Securities as has a Fair Market Value equal to, or as near as possible equal to, the then unpaid Liquidated Damages of such Pledgor (or the Partner who controls such Pledgor); and
(2) received proceeds in the amount of the Fair Market Value of such Pledged Securities and applied such proceeds to the payment of any then unpaid Liquidated Damages of the applicable Pledgor (or the Partner who controls such Pledgor). Any proceeds
from the deemed sale of such Pledged Securities in excess of the then outstanding Liquidated Damages of the applicable Pledgor (or the Partner who controls such Pledgor) will continue to be held as Pledged Securities under this Agreement until
returned in accordance with Section 2(e). Nothing in this Agreement, however, shall require Accenture Ltd to take ownership of or to purchase Pledged Securities in accordance with this Section 3 in order to satisfy an obligation of a Pledgor (or the
Partner who controls such Pledgor) to pay Liquidated Damages. 

 

     (d) If a Payment Event has occurred and is continuing with respect to a Pledgor (or the Partner who controls such Pledgor), (i) with respect to such Pledgor’s Pledged Securities which are not
Accenture Ltd Shares, Accenture Ltd (subject to the terms of the Voting Agreement) shall be entitled to vote such Pledged Securities and to exercise all of such Pledgor’s rights in respect of such Pledged Securities and to receive and retain
all cash dividends and distributions in respect of such Pledged Securities, and other distributions thereon and to give consents, waivers and, if applicable, ratifications in respect thereof, and (ii) with respect to such Pledgor’s Pledged
Securities which are Accenture Ltd Shares, such Pledgor shall issue a proxy in a form acceptable to Accenture Ltd to such person as Accenture Ltd directs which proxy shall give such person all voting rights, the right to give consents, waivers and,
if applicable, ratifications, and the right to exercise all of such Pledgor’s other rights, in each case in respect of such Pledgor’s Accenture Ltd Shares (subject to the terms of the Voting Agreement), and Accenture Ltd shall be permitted
to withhold all cash dividends and distributions and other distributions in respect of such Accenture SCA Shares and all such withheld cash dividends and distributions and other distributions shall become part of the Pledged Securities. 

 
     4. Pledgor’s Obligations Not Affected. Except as provided in Section 10(b), the obligations of any Pledgor under this Agreement shall remain in full force and effect without
regard to, and shall not be impaired or affected by (a) any subordination, amendment or modification of or addition or supplement to this Agreement, the Non-Competition Agreement, or any assignment or transfer thereof; (b) any exercise or
non-exercise by Accenture Ltd of any right, remedy, power or privilege under or in respect of this Agreement, the Non-Competition Agreement, or any waiver of any such right, remedy, power or privilege; (c) any waiver, consent, extension, indulgence
or other action or inaction in respect of this Agreement, the Non-Competition Agreement, or any assignment or transfer of any thereof; (d) any bankruptcy, insolvency, reorganization, arrangement, readjustment, composition, liquidation or the like,
of Accenture Ltd, whether or not any Pledgor shall have notice or knowledge of any of the foregoing; (e) any substitution of collateral pursuant to Section l(b); or (f) any other act or omission to act or delay of any kind by any Pledgor, Accenture
Ltd or any other person or any other circumstance whatsoever which might, but for the provisions of this clause (f), constitute a legal and equitable discharge of any Pledgor’s obligations hereunder.

 
     5. Attorneys-in-Fact. Without prejudice to the terms of Section 1(a), each of Accenture Ltd, and the General Counsel of Accenture Ltd from time to time, acting separately, are
hereby appointed the attorneys-in-fact of each Pledgor for the purpose of carrying out the provisions of this Agreement and taking any action and executing any instrument that Accenture Ltd reasonably may deem necessary or advisable to accomplish
the purposes hereof, which appointments as attorneys-in-fact are irrevocable as ones coupled with an interest. Without limiting the foregoing, each Pledgor specifically authorizes and appoints as attorney-in-fact each of Accenture Ltd and the
General Counsel of Accenture Ltd from time to time, acting separately, to execute and deliver any undated share transfer powers in respect of any certificates or other instruments or documents evidencing the Pledge Securities pledged hereunder by
such Pledgor.

     6. Notices. All notices or other communication required or permitted to be given hereunder shall be delivered as provided in the Non-Competition Agreement. 

     7. No Third Party Beneficiaries. Except as expressly provided herein, this Agreement shall not confer on any person other than Accenture Ltd and the Pledgors any rights or remedies hereunder.

     8. Governing Law. This Agreement and the rights and duties of the parties hereunder shall be governed by and construed and enforced in accordance with the laws of the State of New
York, without regard to principles of conflict of laws, and except to the extent that the validity or perfection of a security interest created hereby or remedies hereunder are governed by the law of a jurisdiction other than the State of New York
as provided herein or in the UCC.

 
     9. Resolution of Disputes. This Agreement shall be subject to the provisions of Sections 2 and 4 of the Non-Competition Agreement, which are incorporated herein by reference and
made a part of this Agreement. Any and all disputes arising out of, relating to or in connection with this Agreement, including, but not limited to, disputes relating to the validity, negotiation, execution, interpretation, performance or
non-performance of this Agreement (including the validity, scope and enforceability of the arbitration provision), shall be finally settled by arbitration in accordance with Section 4 of the Non-Competition Agreement.

     10. Miscellaneous.  
     (a) This Agreement and the Non-Competition Agreement contain the entire understanding and agreement between Pledgors and Accenture Ltd with respect to the matters expressly covered herein
and therein and supersede any other agreement, written or oral, pertaining to such matters.

 
     (b) This Agreement may not be amended or modified with respect to any Pledgor other than by a written agreement executed by such Pledgor and Accenture Ltd or its successors, nor may any
provision hereof be waived other than by a document in writing by the party granting such waiver; provided, that Accenture Ltd may amend or modify this Agreement with respect to any Pledgor without the written consent of such Pledgor if such
amendment or modification (i) is not materially adverse to such Pledgor and (ii) is necessary or desirable in the judgment of a Permitted Prior Pledgee in order to create or perfect the security interest in the Pledged Securities granted to such
Permitted Prior Pledgee. No Pledgor may, directly or indirectly, assign such Pledgor’s rights or obligations hereunder without the prior written consent of Accenture Ltd or its successors, or such individual’s designee, and any such
assignment by such Pledgor in violation of this Agreement shall be void. This Agreement shall be binding upon any Pledgor’s permitted successors and assigns. Without impairing any Pledgor’s obligations hereunder, Accenture Ltd may at any
time and from time to time assign its rights and obligations hereunder to any of its subsidiaries or affiliates (and have such rights and obligations reassigned to it or to any other subsidiary or affiliate). This Agreement shall be binding upon and
inure to the benefit of Accenture Ltd and its successors and assigns.

 

     (c) If any provision of this Agreement is finally held to be invalid, illegal or unenforceable (whether in whole or in part), such provision shall be deemed modified to the extent, but
only to the extent, of such invalidity, illegality or unenforceability and the remaining provisions shall not be affected thereby.

     (d) The captions in this Agreement are for convenience of reference only and shall not define or limit the provisions hereof.  
     (e) Notwithstanding anything herein to the contrary, nothing herein shall be deemed to transfer a beneficial ownership interest in the Class A or Class X common shares of Accenture Ltd to
Accenture Ltd, other than to the extent permitted by Bermuda law.

  
     (f) Accenture Ltd, as issuer of the Covered Shares pledged hereunder by each Pledgor, agrees that it will comply with any instruction received by it from it, as pledgee under this
Agreement, with respect to the Covered Shares pledged hereunder by a Pledgor, without further consent by such Pledgor.

 

     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered on the date first above written. 

	  	

ACCENTURE LTD

By:                              
                         

       Name:

       Title:FORM OF TRANSFER RIGHTS AGREEMENT

 

Exhibit 10.6

 

TRANSFER RIGHTS AGREEMENT

AMONG

ACCENTURE SCA

and

THE COVERED PERSONS SIGNATORY HERETO

Dated as of April 18, 2001

		
	 TABLE OF CONTENTS

	 
	 	 	 
	 	  Page

	 
				 
	
ARTICLE I DEFINITIONS AND OTHER MATTERS
		1	 
				 
	         
Section 1.1. Definitions
		1	 
	         
Section 1.2.  Gender
		4	 
		
	 	 	 	
	
ARTICLE II LIMITATIONS ON TRANSFER OF SHARES
		 5

	
				 
	         
Section 2.1.   Transfer Restrictions
		5	 
	         
Section 2.2.   Release of Transfer Restrictions
		5	 
	         
Section 2.3.   Certain Additional Restrictions
		8	 
	         
Section 2.4.   Holding of Covered Shares in Custody and/or in Nominee Name; Legend on
                                     
Certificates; Entry of Stop Transfer Orders
		8	 
			
	 	 	 
	
ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE PARTIES
 		 10

				 
	
ARTICLE IV OTHER AGREEMENTS OF THE PARTIES
		11	 
				 
	         
Section 4.1.   Redemption Price
		11	 
	         
Section 4.2.   Accenture SCA Partners Committee
		11	 
	         
Section 4.3.   Indemnification and Expenses
		12	 
	         
Section 4.4.   Adjustment upon Changes in Capitalization; Adjustments upon Changes of

                                      
Control; Representatives, Successors and Assigns
		13	 
	       
Section 4.5.   Filing of Schedule 13D or 13G
		14	 
	       
Section 4.6.   Further Assurances
		15	 
				 
	
ARTICLE V MISCELLANEOUS
		15	 
	 			 
	         
Section 5.1.   Term of the Agreement; Termination of Certain Provisions
		15	 
	         
Section 5.2.   Amendments
		15	 
	         
Section 5.3.   Waivers
		16	 
	         
Section 5.4.   Governing Law
		17	 
	         
Section 5.5.   Resolution of Disputes
		17	 
	         
Section 5.6.   Relationship of Parties
		19	 
	         
Section 5.7.   Notices
		19	 
	         
Section 5.8.   Severability
		20	 
	         
Section 5.9.   Right to Determine Tender Confidentially
		20	 
	         
Section 5.10.   No Third-Party Rights
		20	 
	         
Section 5.11.   Section Headings
		20	 
	       
Section 5.12.   Execution in Counterparts
		20	 
				 
	         
Appendix A - Covered Persons
			 

 

 

 

     This Transfer Rights Agreement, dated as of April 18, 2001 (as amended, supplemented, waived or otherwise modified from time to time in accordance with its terms,
this “Agreement”), among Accenture SCA, a Luxembourg société en commandite par actions (“Accenture SCA”), and the Covered Persons (hereinafter defined).

WITNESSETH:

     WHEREAS, the Covered Persons may in the future become beneficial owners of Class I Common Shares, par value 1.25 euro per share, of Accenture SCA (the “Common
Shares”).

     WHEREAS, the Covered Persons desire to address herein certain relationships among themselves with respect to the disposition of their Common Shares and various
other matters and desire to give to the Accenture SCA Partners Committee (hereinafter defined) the power to enforce their agreements with respect thereto on their behalf.

     NOW, THEREFORE, in consideration of the premises and of the mutual agreements, covenants and provisions herein contained, the parties hereto agree as
follows:

ARTICLE I

DEFINITIONS AND OTHER MATTERS

     

Section 1.1. Definitions. The following words and phrases as used herein shall have the following meanings, except as otherwise expressly provided or unless the context otherwise requires: 

     (a) “Accenture Ltd Class A Common Shares” shall mean the Class A Common Shares of Accenture LTD, an exempted company limited by shares organized under the
laws of Bermuda.

     (b) “Accenture SCA” shall have the meaning ascribed to such term in the preamble hereto.

     (c) “Accenture SCA Partners Committee” shall have the meaning ascribed to such term in Section 4.2 hereof.

     (d) This “Agreement” shall have the meaning ascribed to such term in the preamble hereto.

     (e) “Base Eligible Sales” shall have the meaning ascribed to such term in Section 2.2 hereof.

     (f) A “beneficial owner” of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship or
otherwise has, or shares: (i) voting power, which includes the power to vote, or to direct the voting of, such security and/or (ii) investment power, which includes the power to dispose, or to direct the disposition of, such security, but for
purposes of this Agreement a person shall not be deemed a beneficial owner of Common Shares (A) solely by virtue of the application of Exchange Act Rule 13d-3(d) or Exchange Act Rule 13d-5 as in effect on the date hereof, (B) solely by virtue of the
possession of the legal right to vote securities under applicable law (such as by proxy, power of attorney or appointment as corporate representative) or (C) held of record by a “private foundation” subject to the requirements of Section
509 of the Code (or equivalent in other jurisdictions as determined from time to time by the Accenture SCA Partners Committee). “Beneficially own” and “beneficial ownership” shall have correlative meanings. For purposes of the
determination of beneficial ownership only, the provisions of Article II hereof shall not be deemed to transfer the investment power with respect to any Common Shares. 

     (g) “Code” shall mean the United States Internal Revenue Code of 1986, as amended from time to time, and the applicable rulings and regulations
thereunder. 

     (h) “Common Shares” shall have the meaning ascribed to such term in the recitals hereto.

     (i) “Company” shall mean Accenture SCA, together with its general partner and its Subsidiaries from time to time.

     (j) “Continuing Provisions” shall have the meaning ascribed to such term in Section 5.1(b) hereof. 

     (k) “Covered Persons” shall mean those persons, other than Accenture SCA, who are from time to time parties to this Agreement and whose names are, or are
required to be, listed on Appendix A hereto, in each case in accordance with the terms hereof.

     (l) A Covered Person’s “Covered Shares” shall mean any Common Shares beneficially owned by such Covered Person at the time in question but, shall not
include any Common Shares excluded from the definition of Covered Shares by action of the Accenture SCA Partners Committee prior to the IPO Date. “Covered Shares” shall also include the securities that are defined to be “Covered
Shares” in Section 4.4 hereof. A Covered Person “acquires” Covered Shares when such Covered Person first acquires beneficial ownership over such Covered Shares.

     (m) The term “disabled” shall mean “disabled” as defined (i) in any employment agreement then in effect between the employee and the Company, or
(ii) if not defined therein, or if there shall be no such agreement, as defined in the Company’s long-term disability plan as in effect from time to time, or (iii) if there shall be no plan, the inability of an employee to perform in all
material respects his duties and responsibilities to the Company for a period of six (6) consecutive months or for an aggregate of nine (9) months in any twenty-four (24) consecutive month period by reason of a physical or mental incapacity. Any
question as to the existence of a disability as to which the employee and the Company cannot agree shall be determined in writing by a qualified independent physician mutually acceptable to the employee and the Company. If the employee and the
Company cannot agree as to a qualified independent physician, each shall appoint such a physician and those two physicians shall select a third who shall make such determinations in writing. The determination of disability made in writing to the
Company and the employee shall be final and conclusive for all purposes of this Agreement.

     (n) “Disabled Employee” shall have the meaning ascribed to such term in Section 2.2 hereof.

     (o) An “employee” shall include, without limitation, the owners and employees of partner personal service companies in certain countries with which the
Company has personal service contracts (in each case as agreed by the Accenture SCA Partners Committee), and any other similarly situated person designated as an “employee” by the Accenture SCA Partners Committee.

     (p) “Employee Covered Person” shall mean a Covered Person that is an employee of the Company at the time in question, provided that if the Company has
received notice that any Covered Person intends to terminate such Covered Person’s employment with the Company (except in the case of notice with respect to retirement or disability), such Covered Person shall be deemed not to be an Employee
Covered Person.

     (q) “Employee Covered Shares” shall have the meaning ascribed to such term in Section 5.1 hereof.

     (r) “Exchange Act” shall mean the United States Securities Exchange Act of 1934, as amended to date and as further amended from time to time.

     (s) A reference to an “Exchange Act Rule” shall mean such rule or regulation of the United States Securities and Exchange Commission under the Exchange
Act, as in effect from time to time or as replaced by a successor rule thereto.

     (t) “IPO Date” shall mean the closing date of the initial public offering of the Accenture Ltd Class A Common Shares.

     (u) “Market Price of an Accenture Ltd Class A Common Share” shall have the meaning ascribed to such term in the Articles of Association of Accenture SCA,
as such term may be amended from time to time pursuant to the Articles of Association of Accenture SCA.

     (v) “Non-Competition Agreement” shall mean, collectively, any Non-Competition Agreement, dated as of the date hereof, among the Company and the partners
from time to time party thereto.

     (w) “Permitted Basket Transaction” shall mean the purchase or sale of, or the establishment of a long or short position in, a basket or index of
securities (or of a derivative financial instrument with respect to a basket or index of securities) that includes securities of the Company, in each case if such purchase, sale or establishment is permitted under the Company’s policy on
hedging with respect to securities of the Company and other relevant policies, including insider trading policies, as announced from time to time.

     (x) A “person” shall include, as applicable, any individual, estate, trust, corporation, partnership, limited liability company, unlimited liability
company, foundation, association or other entity.

     (y) “Retired Employee” shall have the meaning ascribed to such term in Section 2.2 hereof.

     (z) “Securities Act” shall mean the United States Securities Act of 1933, as amended from time to time.

     (aa) “Sole Beneficial Owner” shall mean a person who is the beneficial owner of Covered Shares, who does not share beneficial ownership of such Covered
Shares with any other person (other than pursuant to this Agreement, the Non-Competition Agreement or applicable community property laws) and who is the only person (other than pursuant to applicable community property laws) with a direct economic
interest in the Covered Shares. An economic interest of the Company (or of any other person with respect to which the Company has expressly agreed to in writing) as pledgee shall be disregarded for this purpose. A Covered Person that holds Covered
Shares indirectly through a wholly-owned personal holding company shall be considered the “Sole Beneficial Owner” of such Covered Shares, provided that such personal holding company is a Covered Person hereunder.

     (bb) “Subsidiary” shall mean any person in which Accenture SCA owns, directly or indirectly, at least a majority of the equity, economic or voting
interest.

     (cc) “Transfer” shall mean any sale, transfer, pledge, hypothecation or other disposition, whether direct or indirect, whether or not for value, and shall
include any disposition of the economic or other risks of ownership of Covered Shares, including short sales of securities of the Company, option transactions (whether physical or cash settled) with respect to securities of the Company, use of
equity or other derivative financial instruments relating to securities of the Company and other hedging arrangements with respect to securities of the Company, in each such case other than Permitted Basket Transactions. 

     (dd) “Transfer Restrictions” shall have the meaning ascribed to such term in Section 2.1 hereof.

     (ee) “Valuation Ratio” shall have the meaning ascribed to such term in the Articles of Association of Accenture SCA, as such ratio may be adjusted from
time to time pursuant to the Articles of Association of Accenture SCA.

     (ff) “vote” shall include, without limitation, actions taken or proposed to be taken by written consent. 

     

Section 1.2. Gender. For the purposes of this Agreement, the words “he,” “his” or “himself” shall be interpreted to include the masculine, feminine and corporate, other entity or trust form.

ARTICLE II

LIMITATIONS ON TRANSFER OF SHARES

     

Section 2.1.   Transfer Restrictions.

     (a) Each Covered Person agrees for the benefit of every other Covered Person that such Covered Person shall at all times be the Sole Beneficial Owner of all Covered
Shares beneficially owned by such Covered Person as of or prior to the IPO Date (such requirements with respect to ownership of Covered Shares, collectively, the “Transfer Restrictions”). 

     

Section 2.2.   Release of Transfer Restrictions

     (a) Notwithstanding Section 2.1, an Employee Covered Person may:

     (i) commencing on the date that is one year after the IPO Date, Transfer up to 10% of the aggregate number of Common Shares beneficially owned by such Employee
Covered Person as of the IPO Date; 

     (ii) commencing on the date that is two years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a)) of
up to 25% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date; 

     (iii) commencing on the date that is three years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a))
of up to 35% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date; 

     (iv) commencing on the date that is four years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a)) of
up to 45% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date; 

     (v) commencing on the date that is five years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a)) of
up to 55% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date; 

     (vi) commencing on the date that is six years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a)) of
up to 65% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date; and 

     (vii) commencing on the date that is seven years after the IPO Date, Transfer an aggregate (together with all other Transfers made pursuant to this paragraph (a))
of up to 75% of the aggregate number of Common Shares beneficially owned by such Employee Covered Person as of the IPO Date. 

       (b) Notwithstanding Section 2.1, a Covered Person may Transfer any Common Shares beneficially owned by such Covered Person as of the IPO Date commencing
on the later of (i) the date that is eight years after the IPO Date and (ii) the date that such Covered Person ceases to be an employee of the Company.

       (c) Notwithstanding Section 2.1, an Employee Covered Person that retires at the age of 50 or older and is not in contravention of the Non-Competition
Agreement (a “Retired Employee”) may, following the first anniversary of the IPO Date:

     (i) if such Retired Employee retires at age 50, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which is
equal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of Common Shares eligible for sale at the date of such retirement
pursuant to paragraph (a) of Section 2.2 (the “Base Eligible Sales”) and (b) the product of (A) (1 minus Base Eligible Sales) multiplied by (B) 0.25;  

     (ii) if such Retired Employee retires at age 51, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which is
equal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of the Base Eligible Sales and (b) the product of (A) (1 minus Base
Eligible Sales) multiplied by (B) 0.375;  

     (iii) if such Retired Employee retires at age 52, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which
is equal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of the Base Eligible Sales and (b) the product of (A) (1 minus Base
Eligible Sales) multiplied by (B) 0.50;  

     (iv) if such Retired Employee retires at age 53, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which is
equal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of the Base Eligible Sales and (b) the product of (A) (1 minus Base
Eligible Sales) multiplied by (B) 0.625;  

     (v) if such Retired Employee retires at age 54, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which is
equal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of the Base Eligible Sales and (b) the product of (A) (1 minus Base
Eligible Sales) multiplied by (B) 0.75; 

 

     (vi) if such Retired Employee retires at age 55, Transfer up to that number of Common Shares beneficially owned by such Retired Employee as of the IPO Date which is
equal to the product of (x) the aggregate number of Common Shares beneficially owned by such Retired Employee as of the IPO Date multiplied by (y) the sum of (a) the percentage of the Base Eligible Sales and (b) the product of (A) (1 minus Base
Eligible Sales) multiplied by (B) 0.875; and  

     (vii) if such Retired Employee retires at age 56 or above, Transfer 100% of the Common Shares beneficially owned by such Retired Employee as of the IPO Date.

     A Retired Employee may also Transfer the Common Shares beneficially owned by such Retired Employee as of the IPO Date in accordance with paragraph (a) of this
Section 2.2 as if such Retired Employee were an Employee Covered Person.

     Following the first anniversary of the IPO Date, a Retired Employee that reaches the age of 56 may also Transfer 100% of the Common Shares beneficially owned by
such Retired Employee as of the IPO Date.

     (d) Notwithstanding Section 2.1, a Covered Person that becomes disabled while an employee of the Company (a “Disabled Employee”) prior to May 31, 2001 (or
such other date that the Accenture SCA Partners Committee shall declare to be the date of the consummation of the Company’s transition to a corporate structure), may Transfer 100% of Common Shares beneficially owned by such Disabled Employee as
of the IPO Date, following the first anniversary of the IPO Date. A Covered Person that becomes a Disabled Employee following May 31, 2001 (or such other date that the Accenture SCA Partners Committee shall declare to be the date of the consummation
of the Company’s transition to a corporate structure) may (i) if such Disabled Employee becomes disabled prior to reaching the age of 50, Transfer Common Shares beneficially owned by such Disabled Employee as of the IPO Date in accordance with
the provisions of paragraph (a) of this Section 2.2 as if such Disabled Employee were an Employee Covered Person and (ii) if such Disabled Employee becomes disabled after reaching the age of 50, Transfer Common Shares beneficially owned by such
Disabled Employee as of the IPO Date in accordance with the provisions of paragraph (c) of this Section 2.2 as if such Disabled Employee were a Retired Employee.

     (e) Notwithstanding Section 2.1, a Covered Person may Transfer Common Shares beneficially owned by such Covered Person as of the IPO Date pursuant to bona fide
pledges of Common Shares approved by Accenture SCA in writing and any foreclosures thereunder, provided that the pledgee has agreed in writing with Accenture SCA (any such agreement to be satisfactory to Accenture SCA in its sole discretion) that
Accenture SCA shall have a right of first refusal to purchase such Common Shares at the market price prior to any sale of such Common Shares by such pledgee.

     (f) Notwithstanding Section 2.1, commencing on the third anniversary of May 31, 2001 (or such other date that the Accenture SCA Partners Committee shall declare to
be the date of the consummation of the Company’s transition to a corporate structure), the Common Shares are redeemable at the option of the Covered Person for a redemption price per share equal to the lower of (i) the Valuation Ratio
multiplied by the Market Price of an Accenture Ltd Class A Common Share and (ii) one United States dollar.

Section 2.3.   Certain Additional Restrictions.

     Each Covered Person agrees for the benefit of every other Covered Person that for so long as such Covered Person is an Employee Covered Person, such Covered Person
will comply with any restrictions on Transfer relating to Common Shares imposed by the Company and notified to such Covered Person from time to time to enable the Company or any party to an agreement with the Company to (i) account for a business
combination by the pooling of interests method or (ii) pursuant to the Company’s insider trading policies from time to time.

     

Section 2.4.  Holding of Covered Shares in Custody and/or in Nominee Name; Legend on Certificates; Entry of Stop Transfer Orders. 

     (a) Each Covered Person understands and agrees that all Covered Shares beneficially owned by such Covered Person (in each case other than Covered Shares held of
record by a trustee in a compensation or benefit plan administered by the Company and other Covered Shares that have been pledged to the Company (or to a third party agreed to in writing by the Company) to secure the performance of such Covered
Person’s obligations under any agreement with the Company (or with any other person with respect to which the Company has expressly agreed to in writing)) shall, at the sole discretion of the Accenture SCA Partners Committee, be registered in
the name of a nominee for such Covered Person and/or shall be held in the custody of a custodian until otherwise determined by the Accenture SCA Partners Committee or until such time as such Covered Shares are released pursuant to paragraphs (e) or
(f) of this Section 2.4 and, by his signature hereto, each Covered Person appoints the Accenture SCA Partners Committee, and each member thereof individually, with full power of substitution and resubstitution, his true and lawful attorney-in-fact
to assign, endorse and register for transfer into such nominee’s name or deliver to such custodian any such Covered Shares which are not so registered or so held, as the case may be, and to enter into any custody agreement with respect to such
Covered Shares, granting to such attorneys, and each of them, full power and authority to do and perform each and every act and thing whatsoever that such attorney or attorneys may deem necessary, advisable or appropriate to carry out fully the
intent of this paragraph (a) of this Section 2.4 as such Covered Person might or could do personally, hereby ratifying and confirming all acts and things that such attorney or attorneys may do or cause to be done by virtue of this power of attorney.
It is understood and agreed by each such Covered Person that this appointment, empowerment and authorization may be exercised by the aforementioned persons with respect to all Covered Shares of such Covered Person, and held of record by another
person, for the period beginning on the date hereof and ending on the date this Agreement shall have been terminated pursuant to Section 5.1(a) hereof. The form of the custody agreement and the identity of the custodian and/or nominee shall be as
determined by the Accenture SCA Partners Committee from time to time.

     (b) Whenever any nominee holder shall receive any dividend or other distribution in respect of any Covered Shares, satisfied otherwise than in Covered Shares, the
Accenture SCA Partners Committee will give or cause to be given notice or direction to the applicable nominee and/or custodian referred to in paragraph (a) to permit the prompt distribution of such dividend or distribution to the beneficial owner of
such Covered Shares, net of any tax withholding amounts required to be withheld by the nominee, unless the distribution of such dividend or distribution is restricted by the terms of another agreement between the Covered Person and the Company (or
with any other person with respect to which the Company has expressly agreed in writing) known to the Accenture SCA Partners Committee.

     (c) Each Covered Person understands and agrees that any share certificate representing Covered Shares beneficially owned by such Covered Person, and any agreement
or other instrument evidencing restricted share units, options or other rights to receive or acquire Covered Shares beneficially owned by such Covered Person, may bear a legend noted conspicuously on each such certificate, agreement or other
instrument reading substantially as follows: 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE PROVISIONS OF A TRANSFER RIGHTS AGREEMENT AMONG ACCENTURE SCA AND THE PERSONS NAMED THEREIN, A COPY OF WHICH IS ON FILE AT
THE PRINCIPAL OFFICE OF ACCENTURE SCA AND WHICH, AMONG OTHER MATTERS, PLACES RESTRICTIONS ON THE DISPOSITION OF SUCH SECURITIES. THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY BE SOLD, EXCHANGED, TRANSFERRED, ASSIGNED, PLEDGED, PARTICIPATED,
HYPOTHECATED OR OTHERWISE DISPOSED OF ONLY IN ACCORDANCE THEREWITH.”

     (d) Each Covered Person agrees and consents (i) that the Board of Directors may refuse to register the transfer of and (ii) to the entry of stop transfer orders
against the transfer of Covered Shares subject to Transfer Restrictions except in compliance with this Agreement. 

     (e) All Covered Shares of each Covered Person who is not an Employee Covered Person which could then be Transferred without contravening any Transfer Restrictions
shall be released, pursuant to procedures to be developed by the Accenture SCA Partners Committee, to or at the direction of such Covered Person free and clear of all restrictions and legends described in this Section 2.4.

     (f) A specified number of Covered Shares of an Employee Covered Person shall be released, pursuant to procedures to be developed by the Accenture SCA Partners
Committee, upon the request of such Employee Covered Person and to or at the direction of such Employee Covered Person (free and clear of all restrictions and legends described in this Section 2.4), provided that such request is accompanied by a
certificate of such requesting Employee Covered Person (i) indicating such requesting Employee Covered Person’s intention to Transfer promptly such specified number of Covered Shares and (ii) establishing that such specified number of Covered
Shares are then permitted to be Transferred without contravening any Transfer Restrictions (which evidence must be satisfactory to the Accenture SCA Partners Committee).

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE PARTIES

        Each Covered Person severally represents and warrants that: 

     (i) such Covered Person has (and with respect to Covered Shares to be acquired in the future, will have) good, valid and marketable title to the Covered Shares,
free and clear of any pledge, lien, security interest, charge, claim, equity or encumbrance of any kind, other than pursuant to this Agreement, another agreement with the Company, or any other agreement with another person with respect to which the
Company has expressly agreed to in writing, by which such Covered Person is bound and to which the Covered Shares are subject;  

     (ii) this Agreement constitutes the legal, valid and binding obligation of such Covered Person, enforceable against such Covered Person in accordance with its terms
(subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally and to general equitable principles (whether considered in a
proceeding in equity or at law));  

     (iii) there are no actions, suits or proceedings pending, or, to the knowledge of such Covered Person, threatened against or affecting such Covered Person or such
Covered Person’s assets in any court or before or by any federal, state, municipal or other domestic or foreign governmental department, commission, board, bureau, agency or instrumentality which, if adversely determined, would impair the
ability of such Covered Person to perform or comply with this Agreement;  

     (iv) such Covered Person understands that his ability to transfer the Covered Shares is subject to legal and contractual restrictions and that the Covered Shares
have not been registered under the United States Securities Act of 1933, and that he is holding the Covered Shares for his own account, for investment, and not for distribution, assignment or resale to others, and no other person has any direct or
indirect beneficial interest in such shares (other than the Company or at the express written consent of the Company); and  

     (v) no statement, representation or warranty made by such Covered Person in this Agreement, nor any information provided by such Covered Person for inclusion in a
report filed pursuant to Section 4.5 hereof or in a registration statement filed by the Company contains or will contain any untrue statement of a material fact or omits or will omit to state a material fact necessary in order to make the
statements, representations or warranties contained herein or information provided therein not misleading. 

        Each Covered Person that is not a natural person additionally and severally represents and warrants that:

     (i) such Covered Person is duly organized and validly existing in good standing under the laws of the jurisdiction of such Covered Person’s formation; 

     (ii) such Covered Person has full right, power and authority to enter into and perform this Agreement; and 

     (iii) the execution and delivery of this Agreement and the performance of the transactions contemplated herein have been duly authorized, and no further proceedings
on the part of such Covered Person are necessary to authorize the execution, delivery and performance of this Agreement; and this Agreement has been duly executed by such Covered Person. 

        Each Covered Person severally agrees that the foregoing provisions of this Article III shall be continuing representations and warranties of such
Covered Person during the period that such person shall be a Covered Person and Common Shares of such person shall be Covered Shares, and such Covered Person shall take all actions as shall from time to time be necessary to cure any breach or
violation and to obtain any authorizations, consents, approvals and clearances in order that such representations and warranties shall be true and correct during such period. 

ARTICLE IV

OTHER AGREEMENTS OF THE PARTIES

        

Section 4.1.   Redemption Price

        Each Covered Person agrees that the redemption price payable in connection with any redemption of such Covered Person’s Common Shares (i)
under Article 7 of the Articles of Association of Accenture SCA, as such redemption price is calculated in accordance with such Article 7, or (ii) under paragraph (f) of Section 2.2 hereof, as such redemption price is calculated in accordance with
Section 2.2 hereof, may, at the option of Accenture SCA, be paid in cash or in Accenture Ltd Class A Common Shares.

        

Section 4.2.   Accenture SCA Partners Committee.

        (a) The “Accenture SCA Partners Committee”, as of any time, shall consist of the members of the Supervisory Board of Accenture SCA who
are also employees of the Company that hold the “Partner” title and who agree to serve as members of the Accenture SCA Partners Committee. If there are less than three individuals who are both Partners and members of the Supervisory Board
of Accenture SCA and who agree to serve as members of the Accenture SCA Partners Committee, the Accenture SCA Partners Committee shall consist of each such individual plus such additional individuals who are Partners and who are selected pursuant to
procedures established by the Accenture SCA Partners Committee as shall ensure that the Accenture SCA Partners Committee contains not less than three members who are Partners. The members of the Accenture SCA Partners Committee from time to time
will be party to this Agreement in their capacities both as Covered Persons and as members of the Accenture SCA Partners Committee. Any member of the Accenture SCA Partners Committee that is not a Covered Person hereunder shall be deemed to be a
party hereto solely in their capacity as a member of the Accenture SCA Partners Committee.

     (b) (i) Except as otherwise provided herein, all determinations necessary or advisable under this Agreement (including determinations of beneficial ownership) shall
be made by the Accenture SCA Partners Committee, whose determinations shall be final and binding. The Accenture SCA Partners Committee’s determinations under this Agreement and actions (including waivers) hereunder need not be uniform and may
be made selectively among Covered Persons (whether or not such Covered Persons are similarly situated).

     (ii) Each Covered Person recognizes and agrees that each of the members of the Accenture SCA Partners Committee in acting hereunder shall at all times be acting in
their individual capacities and not as directors or officers of the Company and in so acting or failing to act shall not have any fiduciary duties to the Company or the Covered Persons as a member of the Accenture SCA Partners Committee by virtue of
the fact that one or more of such members may also be serving as a director or officer of the Company or otherwise. Each Covered Person consequently recognizes that for a member of the Accenture SCA Partners Committee to also serve as a director or
officer of the Company does not constitute a conflict.

     (iii) The Accenture SCA Partners Committee shall act through a majority vote of its members. Such actions may be taken in person at a meeting or by a written
instrument signed by all of the members. Meetings of the Accenture SCA Partners Committee may be held by such telephonic or other electronic means as the Accenture SCA Partners Committee may from time to time approve and which permit all persons
participating in the meeting to communicate with each other simultaneously and instantaneously and participation in such a meeting shall constitute presence in person at such a meeting.

     (c) To the extent not addressed herein, actions to be taken pursuant to this Agreement shall be governed by procedures to be developed by the Accenture SCA Partners
Committee.

     

Section 4.3.   Indemnification and Expenses.

     (a) Accenture SCA agrees that it will indemnify and hold harmless each member of the Accenture SCA Partners Committee against any judgments, fines, losses, claims,
damages or liabilities incurred by them in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of matters that pertain to this Agreement or the transactions
contemplated hereby. Accenture SCA need not indemnify any member of the Accenture SCA Partners Committee against any judgments, fines, losses, claims, damages or liabilities incurred by the Accenture SCA Partners Committee through the Accenture SCA
Partners Committee’s own gross negligence, bad faith or willful misconduct.

     (b) Accenture SCA shall be responsible for all expenses of the Accenture SCA Partners Committee incurred in the operation and administration of this Agreement,
including expenses incurred in preparing appropriate filings and correspondence with the United States Securities and Exchange Commission or other securities regulators, lawyers’, accountants’, agents’, consultants’,
experts’, investment banking and other professionals’ fees, expenses incurred in enforcing the provisions of this Agreement, expenses incurred in maintaining any necessary or appropriate books and records relating to this Agreement and
expenses incurred in the preparation of amendments to and waivers of provisions of this Agreement.

     (c) Each Covered Person shall be responsible for all expenses of such Covered Person incurred in connection with the compliance by such Covered Person with his
obligations under this Agreement, including expenses incurred by the Accenture SCA Partners Committee or Accenture SCA in enforcing the provisions of this Agreement relating to such obligations.

     

Section 4.4.   Adjustment upon Changes in Capitalization; Adjustments upon Changes of Control; Representatives, Successors and Assigns.

     (a) In the event of any change in the outstanding Common Shares by reason of stock dividends, stock splits, reverse stock splits, spin-offs, split-ups,
recapitalizations, combinations, exchanges of shares and the like, the term “Covered Shares” shall refer to and include the securities received or resulting therefrom, but only to the extent such securities are received in exchange for or
in respect of Covered Shares. Upon the occurrence of any event described in the immediately preceding sentence, the Accenture SCA Partners Committee shall make such adjustments to or interpretations of the provisions of Sections 2.1, 2.2 and 4.1
(and, if they so determine, any other provisions hereof) as they shall deem necessary or desirable to carry out the intent of such provision(s). If the Accenture SCA Partners Committee deems it desirable, any such adjustments may take effect from
the record date, the “when issued trading date”, the “ex dividend date” or another appropriate date. 

     (b) In the event of any business combination, amalgamation, restructuring, recapitalization or other extraordinary transaction directly or indirectly involving
Accenture SCA, its Subsidiaries or any of their respective securities or assets as a result of which the Covered Persons shall hold voting securities of an entity other than Accenture SCA, the Covered Persons agree that this Agreement shall also
continue in full force and effect with respect to such voting securities of such other entity formerly representing or distributed in respect of Covered Shares of Accenture SCA, and the terms “Covered Shares,” “Common Shares”,
“Employee Covered Shares,” and “Accenture SCA” and “Company,” shall refer to such voting securities formerly representing or distributed in respect of Covered Shares of Accenture SCA and such entity, respectively. Upon
the occurrence of any event described in the immediately preceding sentence, the Accenture SCA Partners Committee shall make such adjustments to or interpretations of the restrictions of Section 2.1 (and, if it so determines, any other provisions
hereof) as they shall deem necessary or desirable to carry out the intent of such provision(s). If the Accenture SCA Partners Committee deems it desirable, any such adjustments may take effect from the record date or another appropriate
date.

     (c) In the event of any business combination, amalgamation, restructuring, recapitalization or other extraordinary transaction directly or indirectly involving the
Company or any of its securities or assets as a result of which the holders of Accenture Ltd Class A Common Shares shall hold voting securities of a different entity, the Covered Persons agree that the term “Accenture Ltd Class A Common
Shares” shall refer to such voting securities formerly representing or distributed in respect of Accenture Ltd Class A Common Shares. Upon the occurrence of any event described in the immediately preceding sentence, the Accenture SCA Partners
Committee shall make such adjustments to or interpretations of Section 2.2 or 4.1 (and, if it so determines, any other provisions hereof) as it shall deem necessary or desirable to carry out the intent of such provision(s). If the Accenture SCA
Partners Committee deems it desirable, any such adjustments may take effect from the record date or another appropriate date.

     (d) This Agreement shall be binding upon and inure to the benefit of the respective legatees, legal representatives, successors and assigns of the Covered Persons
(and Accenture SCA in the event of a transaction described in Section 4.4(b) hereof); provided, however, that a Covered Person may not assign this Agreement or any of his rights or obligations hereunder without the prior written consent of Accenture
SCA, and any assignment without such consent by a Covered Person shall be void; and, provided, further, that no assignment of this Agreement by Accenture SCA or to a successor of Accenture SCA (by operation of law or otherwise) shall be valid unless
such assignment is made to a person which succeeds to the business of Accenture SCA substantially as an entirety.

     

Section 4.5.   Filing of Schedule 13D or 13G.

     (a) In the event that a Covered Person is required to file a report of beneficial ownership on Schedule 13D or 13G with respect to the Common Shares beneficially
owned by him (for this purpose as determined by Exchange Act Rule 13d-3 and Exchange Act Rule 13d-5), such Covered Person agrees for the benefit of every other Covered Person that, unless otherwise directed by the Accenture SCA Partners Committee,
such Covered Person will not file a separate such report, but will file a report together with the other Covered Persons, containing the information required by the Exchange Act, and such Covered Person understands and agrees that such report shall
be filed on his behalf by the Accenture SCA Partners Committee or any member or designee thereof. Such Covered Person shall cooperate fully with the other Covered Persons and the Accenture SCA Partners Committee to achieve the timely filing of any
such report and any amendments thereto as may be required, and such Covered Person agrees that any information concerning such Covered Person which such Covered Person furnishes in connection with the preparation and filing of such report will be
complete and accurate.

     By his signature hereto, each Covered Person appoints the Accenture SCA Partners Committee and each member thereof from time to time individually, with full power
of substitution and resubstitution, his true and lawful attorney-in-fact to execute such reports and any and all amendments thereto and to file such reports with all exhibits thereto and other documents in connection therewith with the United States
Securities and Exchange Commission and, if necessary, other regulators, granting to such attorneys, and each of them, full power and authority to do and perform each and every act and thing whatsoever that such attorney or attorneys may deem
necessary, advisable or appropriate to carry out fully the intent of this Section 4.5 as such Covered Person might or could do personally, hereby ratifying and confirming all acts and things that such attorney or attorneys may do or cause to be done
by virtue of this power of attorney. Each Covered Person hereby further designates such attorneys as such Covered Person’s agents authorized to receive notices and communications with respect to such reports and any amendments thereto. It is
understood and agreed by each such Covered Person that this appointment, empowerment and authorization may be exercised by the aforementioned persons for the period beginning on the date hereof and ending on the date such Covered Person is no longer
subject to the provisions of this Agreement (and shall extend thereafter for such time as is required to reflect that such Covered Person is no longer a party to this Agreement). 

Section 4.6. Further Assurances. Each Covered Person agrees for the benefit of every other Covered Person to execute such additional documents and take such further action as may be reasonably necessary to effect the provisions of this
Agreement.

ARTICLE V

MISCELLANEOUS

     

Section 5.1.   Term of the Agreement; Termination of Certain Provisions.

     (a) The term of this Agreement shall continue until the first to occur of the date that is 50 years after the date hereof and the date this Agreement is terminated
by the affirmative vote of not less than 66 2/3% of the votes represented by the Covered Shares beneficially owned by Employee Covered Persons (such Covered Shares at any such time, the “Employee Covered Shares”). The Accenture SCA
Partners Committee may, and upon the written application of the holders of not less than 10%, in the aggregate, of the votes represented by the Employee Covered Shares shall, hold a vote of the Employee Covered Shares to terminate this Agreement. If
this Agreement is terminated prior to the expiration or termination of the Transfer Restrictions referred to in Section 2.1, such restrictions on transfer shall continue to apply in accordance with the provisions of such Section unless waived or
terminated as provided in paragraph (b) or (e) of Section 5.3. 

     Not less than once every four years following the IPO Date, the Accenture SCA Partners Committee shall consider whether to propose to the Employee Covered Persons
any amendments to, or the termination of, this Agreement. 

     (b) Unless this Agreement is theretofore terminated pursuant to Section 5.1(a) hereof, any Covered Person who ceases to be an employee for any reason other than
death shall continue to be bound by all the provisions of this Agreement until such time as such Covered Person holds all Covered Shares free from Transfer Restrictions. Thereafter, such Covered Person shall no longer be bound by the provisions of
this Agreement other than Sections 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, 5.10 and 5.11 (the “Continuing Provisions”), and such Covered Person’s name shall be removed from Appendix A to this
Agreement.

     (c) Unless this Agreement is theretofore terminated pursuant to Section 5.1(a) hereof, the estate of any Covered Person who dies shall from and after the date of
such death be bound only by the Continuing Provisions; and such Covered Person’s name shall be removed from Appendix A to this Agreement.

     

Section 5.2.   Amendments.

     (a) Except as provided in Section 4.4 or this Section 5.2, provisions of this Agreement may be amended only by the affirmative vote of 66 2/3% of the votes
represented by the Employee Covered Shares. The Accenture SCA Partners Committee may, and upon the written application of the holders of not less than 10%, in the aggregate, of the votes represented by the Employee Covered Shares shall, hold a vote
of the Employee Covered Shares to amend this Agreement.

     (b) In addition to any other vote or approval that may be required under this Section 5.2, any amendment of this paragraph (b), Section 4.2, Section 4.3, paragraph
(e) of Section 5.3 or any other provision the amendment (or addition) of which has the effect of materially changing the rights or obligations of the Accenture SCA Partners Committee hereunder shall require the approval of the Accenture SCA Partners
Committee.

     (c) In addition to any other vote or approval that may be required under this Section 5.2, any amendment to the Transfer Restrictions that would make such Transfer
Restrictions materially more onerous to a Covered Person will not be enforceable against that Covered Person unless that Covered Person has consented to such amendment.

     (d) In addition to any other vote or approval that may be required under this Section 5.2, any amendment of this Agreement that has the effect of changing the
obligations of Accenture SCA hereunder to make such obligations materially more onerous to Accenture SCA shall require the approval of Accenture SCA.

     (e) In addition to any other vote or approval that may be required under this Section 5.2, any amendment that has the effect of amending the provisions of Section
2.1, Section 2.3 or Section 4.1 shall require the approval of Accenture SCA.

     (f) Each party hereto understands that from time to time certain other persons may become Covered Persons and certain Covered Persons will cease to be bound by the
provisions of this Agreement pursuant to the terms hereof. Accordingly, this Agreement may be amended by action of the Accenture SCA Partners Committee from time to time and without the approval of any other person, but solely for the purposes of
(i) adding to Appendix A such persons as shall be made party to this Agreement pursuant to the terms hereof and (ii) removing from Appendix A such persons as shall cease to be bound by the provisions of this Agreement pursuant to Sections 5.1(b) or
(c) hereof, which additions and removals shall be given effect from time to time by appropriate changes to Appendix A.

     (g) Any amendment to this Agreement approved in accordance with the terms hereof by the Employee Covered Persons as of an applicable record date shall be binding
upon all persons who subsequently become a party hereto.

     

Section 5.3.  Waivers.

     (a) Except as provided in this Section 5.3, provisions of this Agreement may be waived only by the affirmative vote of 66 2/3% of the votes represented by the
outstanding Employee Covered Shares. The Accenture SCA Partners Committee may, and upon the written application of the holders of not less than 10%, in the aggregate, of the votes represented by the Employee Covered Shares shall, hold a vote to
waive certain provisions of this Agreement.

     (b) In addition to any other action that may be required under paragraph (a) of this Section, any waiver that has the effect of waiving the provisions of Section
2.1 or Section 2.3 shall require the approval of Accenture SCA.

     (c) In addition to any other vote or approval that may be required under this Section 5.3, any waiver of this paragraph (c), Section 4.2, Section 4.3, paragraph (e)
of this Section 5.3 or any other provision the waiver (or alteration) of which has the effect of materially changing the rights or obligations of the Accenture SCA Partners Committee hereunder shall require the approval of the Accenture SCA Partners
Committee.

     (d) In addition to any other vote or approval that may be required under this Section 5.3, any waiver of this Agreement that has the effect of changing the
obligations of Accenture SCA hereunder to make such obligations materially more onerous to Accenture SCA shall require the approval of Accenture SCA.

     (e) Notwithstanding the foregoing, the Accenture SCA Partners Committee may waive the Transfer Restrictions and the other provisions of this Agreement to permit (A)
Covered Persons to participate as sellers in underwritten public offerings of, and share repurchase programs and tender offers by the Company for, Common Shares; (B) Transfers of Covered Shares to organizations described in Section 501(c)(3) of the
Code, including gifts to “private foundations” subject to the requirements of Section 509 of the Code or comparable provisions of the laws of other countries; (C) Transfers of Covered Shares held in employee benefit plans of the Company
either generally or in particular situations; and (D) particular Covered Persons, a particular class of Covered Persons or all Covered Persons to Transfer Covered Shares in particular situations (such as Transfers to family members, partnerships or
trusts), but not generally; provided that in each of (A) through (D), waivers of the restrictions imposed by Section 2.3 shall also require the prior written consent of the Company.

     (f) In connection with any waiver granted under this Agreement, the Accenture SCA Partners Committee or the Employee Covered Persons proposing the waiver pursuant
to this Section 5.3, as the case may be, may impose such conditions as they determine on the granting of such waivers.

     (g) The failure of Accenture SCA or the Accenture SCA Partners Committee at any time or times to require performance of any provision of this Agreement shall in no
manner affect the rights at a later time to enforce the same. No waiver by Accenture SCA or the Accenture SCA Partners Committee of the breach of any term contained in this Agreement, whether by conduct or otherwise, in any one or more instances,
shall be deemed to be or construed as a further or continuing waiver of any such breach or the breach of any other term of this Agreement.

     

Section 5.4.   GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF LUXEMBOURG.

     

Section 5.5.   Resolution of Disputes.

     (a) The Accenture SCA Partners Committee shall have the sole and exclusive power to enforce the provisions of this Agreement. The Accenture SCA Partners Committee
may in their sole discretion direct Accenture SCA to pursue such enforcement, and Accenture SCA agrees to pursue such enforcement as directed by the Accenture SCA Partners Committee. 

     (b) Any and all disputes which cannot be settled amicably, including any ancillary claims of any party, arising out of, relating to or in connection with the
validity, negotiation, execution, interpretation, performance or non-performance of this Agreement (including the validity, scope and enforceability of this arbitration provision) shall be finally settled by arbitration conducted by a single
arbitrator in New York in accordance with the then-existing Rules of Arbitration of the International Chamber of Commerce, except that the parties may select an arbitrator who is a national of the same country as one of the parties. If the parties
to the dispute fail to agree on the selection of an arbitrator within thirty (30) days of the receipt of the request for arbitration, the International Chamber of Commerce shall make the appointment. The arbitrator shall be a lawyer and shall
conduct the proceedings in the English language. 

     Performance under this Agreement shall continue if reasonably possible during any arbitration proceedings.

     (c) Notwithstanding the provisions of paragraph (b), the Accenture SCA Partners Committee may bring, or may cause Accenture SCA to bring, on behalf of the Accenture
SCA Partners Committee or on behalf of one or more Covered Persons, an action or special proceeding in any court of competent jurisdiction for the purpose of compelling a party to arbitrate, seeking temporary or preliminary relief in aid of an
arbitration hereunder, and/or enforcing an arbitration award and, for the purposes of this paragraph (c), each Covered Person (i) expressly consents to the application of paragraph (d) of this Section 5.5 to any such action or proceeding, (ii)
agrees that proof shall not be required that monetary damages for breach of the provisions of this Agreement would be difficult to calculate and that remedies at law would be inadequate, and (iii) irrevocably appoints the General Partner of
Accenture SCA 398 Route d’Esch, L-1471, Luxembourg (or, if different, the then-current corporate seat of Accenture SCA) as such Covered Person’s agent for service of process in connection with any such action or proceeding and agrees that
service of process upon such agent, who shall promptly advise such Covered Person of any such service of process, shall be deemed in every respect effective service of process upon the Covered Person in any such action or proceeding.

     (d) (i) EACH COVERED PERSON HEREBY IRREVOCABLY SUBMITS TO THE JURISDICTION OF COURTS LOCATED IN NEW YORK, UNITED STATES FOR THE PURPOSE OF ANY JUDICIAL PROCEEDING
BROUGHT IN ACCORDANCE WITH THE PROVISIONS OF PARAGRAPH (C) OF THIS SECTION 5.5, OR ANY JUDICIAL PROCEEDING ANCILLARY TO AN ARBITRATION OR CONTEMPLATED ARBITRATION ARISING OUT OF OR RELATING TO OR CONCERNING THIS AGREEMENT. Such ancillary judicial
proceedings include any suit, action or proceeding to compel arbitration, to obtain temporary or preliminary judicial relief in aid of arbitration, or to confirm an arbitration award. The parties acknowledge that the fora designated by this
paragraph (d) have a reasonable relation to this Agreement, and to the parties’ relationship with one another. 

     (ii) The parties hereby waive, to the fullest extent permitted by applicable law, any objection which they now or hereafter may have to personal jurisdiction or to
the laying of venue of any such ancillary suit, action or proceeding brought in any court referred to in paragraph (d)(i) of this Section 5.5 and such parties agree not to plead or claim the same. 

     

Section 5.6.  Relationship of Parties. The terms of this Agreement are not intended to create a separate entity for United States federal or state income tax purposes or under the laws of any other jurisdiction. Nothing in this Agreement
shall be read to create any partnership, joint venture or separate entity among the parties or to create any trust or other fiduciary relationship between them.

     

Section 5.7.  Notices.

     (a) Any communication, demand or notice to be given hereunder will be duly given (and shall be deemed to be received) when delivered in writing by hand or first
class mail or by telecopy to a party at its address as indicated below:

If to a Covered Person,

c/o Accenture SCA

398 Route d’Esch

L-1471

Luxembourg

Telecopy: (352) 48 18 28 3419

Attention: General Partner

(or, if different, the then-current corporate seat of Accenture SCA)

If to the Accenture SCA Partners Committee, 

c/o Accenture SCA

398 Route d’Esch

L-1471

Luxembourg

Telecopy: (352) 48 18 28 3419

Attention: General Partner

(or, if different, the then-current corporate seat of Accenture SCA)

and

If to Accenture SCA,

398 Route d’Esch

L-1471

Luxembourg

Telecopy: (352) 48 18 28 3419

Attention: General Partner

(or, if different, the then-current corporate seat of Accenture SCA)

     Accenture SCA shall be responsible for notifying each Covered Person of the receipt of a communication, demand or notice under this Agreement relevant to such
Covered Person, in writing, at the address of such Covered Person then in the records of Accenture SCA (and each Covered Person shall notify Accenture SCA of any change in such address for communications, demands and notices) or by electronic mail
to the principal electronic address of such person maintained by the Company.

     (b) Unless otherwise provided to the contrary herein, any notice which is required to be given in writing pursuant to the terms of this Agreement may be given by
telecopy. 

     

Section 5.8.  Severability.  If any provision of this Agreement is finally held to be invalid, illegal or unenforceable, the remaining terms and provisions hereof shall be unimpaired. 

     

Section 5.9.  Right to Determine Tender Confidentially. In connection with any tender or exchange offer for all or any portion of the outstanding Common Shares, subject to compliance with all applicable restrictions on Transfer in this
Agreement or any other agreement with the Company, each Covered Person shall have the right to determine confidentially whether such Covered Person’s Covered Shares will be tendered in such tender or exchange offer.

     

Section 5.10.  No Third-Party Rights. Nothing expressed or referred to in this Agreement will be construed to give any person other than the parties to this Agreement any legal or equitable right, remedy, or claim under or with
respect to this Agreement or any provision of this Agreement. This Agreement and all of its provisions and conditions are for the sole and exclusive benefit of the parties to this Agreement and their successors and permitted assigns.

     

Section 5.11.  Section Headings. The headings of sections in this Agreement are provided for convenience only and will not affect its construction or interpretation.

     

Section 5.12.  Execution in Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute one agreement.

     IN WITNESS WHEREOF, the parties hereto have duly executed or caused to be duly executed this Transfer Rights Agreement as of the date first above written.

     ACCENTURE SCA

     By: ACCENTURE LTD, its General Partner

     By _________________________________

           Name:

           Title:

[Signature blocks of Covered Persons set forth separately.]

APPENDIX A

Covered Persons

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00024-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00024-of-00352.parquet"}]]